Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

AgonOx and MedImmune join to develop TNF receptor superfamily member 4 agonists

Nov. 3, 2011

MorphoSys and Shionogi extend HuCAL research partnership

Nov. 2, 2011

Takara Bio to develop gene therapy for non-Hodgkin's lymphoma

Nov. 2, 2011

Oxford BioMedica and Mayo Clinic to collaborate on gene therapy for chronic glaucoma

Oct. 31, 2011

Biogen Idec and Portola enter collaboration for SYK inhibitors

Oct. 31, 2011

The Medicines Company and Daiichi Sankyo to copromote anticoagulant in Germany

Oct. 31, 2011

Marshall Edwards and Ausio Pharmaceuticals enter licensing agreement for AUS-131

Oct. 28, 2011

Bristol-Myers Squibb and Gilead Sciences enter licensing agreement for antiretroviral regimen

Oct. 27, 2011

California Stem Cell acquires stem cell therapy program for metastatic melanoma

Oct. 26, 2011

RetroSense Therapeutics licenses gene therapy from Wayne State University

Oct. 26, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...